ERAS and ABBV Related Headlines

Go Back

Jan 7, 2026 03:09PM Revolution Medicines stock surges over 20% on potential AbbVie acquisition

ERAS and ABBV Related Press Releases

Go Back

ERAS and ABBV Related SEC Filings

Go Back